These findings suggest that lncRNA-UCA1 overexpression is orchestrated by the transcription factor HIF-1α in hypoxic breast cancer and that targeting this pathway could be a promising strategy for cancer therapy. The gene discussed is UCA1; the disease is breast cancer.